<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03375892</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00030436</org_study_id>
    <nct_id>NCT03375892</nct_id>
  </id_info>
  <brief_title>The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure</brief_title>
  <official_title>A Phase II Study of the Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to discover more about radiation techniques for people treated for left-sided&#xD;
      breast cancer that minimizes exposure to the heart, as noted by mean heart dose.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to discover more about radiation techniques for people treated for left-sided&#xD;
      breast cancer that minimizes exposure to the heart, as noted by mean heart dose. Both prone&#xD;
      (lying face down) radiation and Deep Inspiration Breath Hold (DIBH) are more labor-intensive&#xD;
      and usually require longer treatment times for patients than traditional supine (lying face&#xD;
      up) free-breathing radiation treatments. Thus, identifying people that benefit most from&#xD;
      these techniques can better utilize resources. This study compares supine and prone&#xD;
      positioning, with or without DIBH, to further assess which positioning technique will achieve&#xD;
      the lowest cardiac radiation doses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 3, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in EKG parameters prior to, during or after radiation therapy.</measure>
    <time_frame>Baseline, 6 weeks, 6 months and 12 months</time_frame>
    <description>Changes in QRS wave form will be categorized as 'present' or 'absent' based on the presentation (or lack) of a r' wave, or notched r or s wave on the EKG tracing. QRS-T angle will be measured in degrees.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in mitochondrial energy production, as measured in leukocytes (peripheral blood mononuclear cells) from patients prior to and after undergoing radiation therapy.</measure>
    <time_frame>baseline, 6 weeks, and 6 and 12 months post-radiation therapy</time_frame>
    <description>Mitochondrial energy production will be measured by determining oxygen consumption rate (pmol of O2 consumed per second perÂ·10^6 cells).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricular ejection fraction prior to, during or after radiation therapy.</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>This will be measured as a percentage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left atrial volume prior to, during or after radiation therapy.</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>This will be measured in millimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular wall thickness prior to, during or after radiation therapy.</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>This will be measured in millimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial and aortic stiffness.</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>This will be assessed by measuring the ascending aortic diameters 3 cm above the aortic valve at end-diastole and end-systole in the 2D parasternal view.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Ductal Carcinoma in Situ</condition>
  <condition>Invasive Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Prone Position with DIBH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For prone positioning, patients will be positioned with alpha cradle casts, and a prone breast board.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supine Position with DIBH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For the supine positioning, patients will be positioned with the breast board currently in use in the Department of Radiation Oncology.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prone Position with no DIBH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For prone positioning, patients will be positioned with alpha cradle casts, and a prone breast board.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supine Position with no DIBH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For the supine positioning, patients will be positioned with the breast board currently in use in the Department of Radiation Oncology.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deep Inspiration Breath Hold during Radiation</intervention_name>
    <description>The DIBH technique involves the patient breathing to a specified threshold and then holding that level of inspiration during every radiation therapy field delivered.</description>
    <arm_group_label>Prone Position with DIBH</arm_group_label>
    <arm_group_label>Supine Position with DIBH</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Free breathing during radiation</intervention_name>
    <description>The patient will be instructed to breathe freely.</description>
    <arm_group_label>Prone Position with no DIBH</arm_group_label>
    <arm_group_label>Supine Position with no DIBH</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must have a pathologically proven diagnosis of left-sided invasive breast&#xD;
             cancer or ductal carcinoma in situ receiving breast/chestwall irradiation +/- regional&#xD;
             nodal irradiation, or a right-sided invasive ductal cancer status post-mastectomy or&#xD;
             lumpectomy who will be receiving breast/chest wall and nodal irradiation.&#xD;
&#xD;
          -  Patients must have undergone breast conserving surgery (i.e. lumpectomy, partial&#xD;
             mastectomy) or mastectomy prior to enrollment.&#xD;
&#xD;
          -  Patients must be 18 years of age or older.&#xD;
&#xD;
          -  Study entry must be prior to CT simulation.&#xD;
&#xD;
          -  Per Medical College of Wisconsin Department of Radiation Oncology Standard of Care,&#xD;
             women of childbearing potential must be non-pregnant and non-lactating and willing to&#xD;
             use medically acceptable forms of contraception during radiation therapy. Patients&#xD;
             under age 50 with a uterus and ovaries must have a negative serum pregnancy test&#xD;
             within one week of planned CT simulation per Radiation Oncology Departmental&#xD;
             guidelines prior to CT simulation.&#xD;
&#xD;
          -  Patients must provide study specific informed consent prior to study entry.&#xD;
&#xD;
          -  Patients must be able to hold their breath long enough to undergo CT simulation in&#xD;
             DIBH (ten to fifteen seconds). The patient should also affirm they can lie in the&#xD;
             prone position. This will be determined by the treating radiation oncologist, as per&#xD;
             current standard of care.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are unable to hold their breath long enough to undergo CT simulation in&#xD;
             DIBH. While this may affect patients with chronic obstructive pulmonary disease (COPD)&#xD;
             and/or other respiratory conditions, the presence of these comorbidities alone will&#xD;
             not exclude patients from enrollment so long as they can maintain breath hold long&#xD;
             enough to perform DIBH.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Currey, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Froedtert Hospital and Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 13, 2017</study_first_submitted>
  <study_first_submitted_qc>December 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 18, 2017</study_first_posted>
  <last_update_submitted>July 15, 2021</last_update_submitted>
  <last_update_submitted_qc>July 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical College of Wisconsin</investigator_affiliation>
    <investigator_full_name>Adam Currey</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>radiation</keyword>
  <keyword>Deep Inspiration Breath Hold</keyword>
  <keyword>stage I</keyword>
  <keyword>stage II</keyword>
  <keyword>stage IIa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Carcinoma, Ductal</mesh_term>
    <mesh_term>Carcinoma, Intraductal, Noninfiltrating</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

